Assisted both seller and buyer in intellectual property aspects of acquisition of $200 million OTC pharmaceutical company by $600 million OTC pharmaceutical and household brand products company. Continue to represent combined intellectual property portfolio.
Served as co-defense counsel for spice manufacturer in action brought by U.S. Food and Drug Administration (FDA) in which the FDA sought broad injunctive relief including destruction of inventory based on violations of the Food, Drug and Cosmetic Act. In a published ruling, the U.S. District Court for the Western District of Tennessee recognized the extensive measures undertaken by the manufacturer to ensure compliance with FDA rules and regulations and that much of the relief sought by the government was largely unnecessary.
Assisted a large pharmaceutical company in combating extensive, targeted international registrations of the client's trademarks by a foreign corporation, successfully opposing and/or obtaining assignments of all of the pirate marks, totaling roughly 100.